Deep Learning-based Modeling Enhances Efficacy of Natural Ligand CAR Binders Targeting CD70
Kang, A. S.; Dalal, R.; Li, M.; Ojha, A. A.; Walunj, S.; Cornell, C. E.; Rahnama, R.; Barpanda, A.; Prudhvi, S.; Patel, T.; Aspinall-O'Dea, M.; Walker, B.; Adams, C.; Steri, V.; Phojanakong, P.; Camara Serrano, J. A.; Li, H.; Rivera, J.; Fletcher, D. A.; Huang, B. J.; Hanson, S. M.; Cossio, P.; Kortemme, T.; Eyquem, J.; Wiita, A. P.
Show abstract
CD70 is well-recognized as a promising "pan-cancer: chimeric antigen receptor (CAR) T-cell target. Prior work has shown that a "natural ligand" (NL)-based CAR targeting CD70, employing its physiological interaction partner CD27, may have therapeutic advantages over antibody-based CARs. Yet while antibody-based CARs are routinely optimized by affinity maturation of their scFv, whether the binding sequence of an NL CAR can be engineered to improve its function remains unexplored. Here, we combined deep learning with physics-based modeling to redesign residues at the CD27:CD70 interface, identifying a CD27 variant, "N88A", which enhances the efficacy of CD70-targeting CAR T-cells across models of acute myeloid leukemia, multiple myeloma, and renal cell carcinoma. Biophysical approaches, including molecular dynamics simulations, support a mechanism of increased binder conformational freedom underlying potency enhancement. Our work presents CD27N88A CAR T-cells as a promising new therapeutic option and proposes that computational modeling could be applied to enhance efficacy of other NL-based immunotherapies.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- THLANet: A Deep Learning Framework for Predicting TCR-pHLA Binding in Immunotherapy Applications 92%
- Exploring the Potential of Structure-Based Deep Learning Approaches for T cell Receptor Design 92%
- Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas 90%
Similar papers in this journal
- Towards generalizable prediction of antibody thermostability using machine learning on sequence and structure features 91%
- Prediction of Antibody Non-Specificity using Protein Language Models and Biophysical Parameters 91%
- AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity 91%
Similar papers in this journal
- Multi-strategies embedded framework for neoantigen vaccine maturation 93%
- Exploring the ability of the MD+FoldX method to predict SARS-CoV-2 antibody escape mutations using large-scale data 92%
- The CC′ loop of IgV domain containing immune checkpoint receptors: From a bystander to an active determinant of receptor:ligand binding 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.